Orion Group Financial Statement Release for 2021
February 10, 2022 05:00 ET
|
Orion Oyj
ORION CORPORATION FINANCIAL STATEMENT RELEASE 2021 10 FEBRUARY 2022 at 12:00 Orion Group Financial Statement Release for 2021 This is a summary or Orion’s Financial Statement Release...
ARASENS trial with darolutamide in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer
December 03, 2021 01:30 ET
|
Orion Oyj
ORION CORPORATION STOCK EXCHANGE RELEASE / INSIDE INFORMATION3 DECEMBER 2021 at 8.30 EET ARASENS trial with darolutamide in combination with docetaxel and androgen deprivation...
Global Castrate Resistant Prostate Cancer (CRPC) Market to Surpass US$ 16.4 Billion by 2028, Says Coherent Market Insights (CMI)
July 20, 2021 08:40 ET
|
CMI
SEATTLE, July 20, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global castrate-resistant prostate cancer market is estimated to be valued at US$ 9.5 billion in 2021 and is...
Orion Group Half-Year Financial Report 1-6/2021
July 19, 2021 05:00 ET
|
Orion Oyj
ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1-6/2021 19 JULY 2021 at 12:00 noon EEST Orion Group Half-Year Financial Report 1-6/2021 This is a summary of Orion’s Half-Year Financial...
Orion Group Interim Report 1-3/2021
April 27, 2021 05:00 ET
|
Orion Oyj
ORION CORPORATION INTERIM REPORT 1-3/2021 27 APRIL 2021 at 12:00 noon EEST Orion Group Interim Report 1-3/2021 This is a summary of Orion’s Interim Report 1-3/2021. The complete report...
Global Castrate-resistant Prostate Cancer Market By Therapy, By Region, Industry Analysis and Forecast, 2020 - 2026
February 10, 2021 07:14 ET
|
ReportLinker
New York, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Castrate-resistant Prostate Cancer Market By Therapy, By Region, Industry Analysis and...
US Prostate Cancer Drug Market Outlook to 2026: Comprehensive Clinical Insight on 25 FDA Approved Prostate Cancer Drugs
February 10, 2021 03:38 ET
|
Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
Orion Group Financial Statement Release for 2020
February 09, 2021 05:00 ET
|
Orion Oyj
ORION CORPORATION FINANCIAL STATEMENT RELEASE 2020 9 FEBRUARY 2021 at 12:00 Orion Group Financial Statement Release for 2020 This is a summary or Orion’s Financial Statement...
Orion and Bayer expand development program for darolutamide in prostate cancer
February 08, 2021 07:00 ET
|
Orion Oyj
ORION CORPORATION PRESS RELEASE 8 FEBRUARY 2021 at 14.00 EET Orion and Bayer expand development program for darolutamide in prostate cancer Phase III study ARANOTE...
Orion Group Interim Report 1-9/2020
October 21, 2020 05:00 ET
|
Orion Oyj
ORION CORPORATION INTERIM REPORT 1-9/2020 21 OCTOBER 2020 at 12:00 noon EEST Orion Group Interim Report 1-9/2020 This is a summary of Orion’s Interim Report 1-9/2020. The...